Creo Medical Group (LON:CREO) Reaches New 52-Week Low – Should You Sell?

Creo Medical Group PLC (LON:CREO)’s share price hit a new 52-week low during trading on Thursday . The stock traded as low as GBX 12 ($0.15) and last traded at GBX 12 ($0.15), with a volume of 2507958 shares changing hands. The stock had previously closed at GBX 12.88 ($0.17).

Creo Medical Group Price Performance

The company has a market capitalization of £48.51 million, a price-to-earnings ratio of -1.90 and a beta of 0.86. The company has a debt-to-equity ratio of 29.96, a quick ratio of 2.19 and a current ratio of 3.24. The business’s 50 day moving average is GBX 15.29 and its 200 day moving average is GBX 18.18.

Insider Activity

In other Creo Medical Group news, insider Richard John Rees bought 4,712 shares of Creo Medical Group stock in a transaction that occurred on Thursday, January 16th. The stock was purchased at an average price of GBX 19 ($0.25) per share, with a total value of £895.28 ($1,154.90). Corporate insiders own 22.43% of the company’s stock.

About Creo Medical Group

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.

The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive.